Heflich R H, Djurić Z, Zhuo Z, Fullerton N F, Casciano D A, Beland F A
Department of Health and Human Services, Food and Drug Administration, Jefferson, AR 72079.
Environ Mol Mutagen. 1988;11(2):167-81. doi: 10.1002/em.2850110203.
Chinese hamster ovary (CHO) cells were exposed to 2-acetylaminofluorene (2-AAF) and 2-aminofluorene (2-AF), and several of their N-oxidized metabolites in order to study the mechanisms by which arylamides and arylamines produce mutations in mammalian cells. The number of mutations induced at the hypoxanthine-guanine phosphoribosyl transferase locus by each compound (mutants/10(6) CHO cells/nmol compound/ml) was estimated to be: N-acetoxy-2-AAF, 310; N-hydroxy-2-AF, 3; N-hydroxy-2-AAF (with and without hepatic S9 activation), 0.7; 2-AAF (with S9), 0.1; and 2-AF (with S9), 0.09. With each compound, DNA adducts were also identified and quantified, and in all cases the major adduct was N-(deoxyguanosin-8-yl)-2-AF. 2-AAF and N-hydroxy-2-AAF also formed minor amounts of N-(deoxyguanosin-8-yl)-2-AAF and 3-(deoxyguanosin-N2-yl)-2-AAF. The relationship between mutation induction and adduct formation for each of the derivatives was similar to that previously reported for N-hydroxy-2-AF. Inclusion of the deacetylase inhibitor, paraoxon, reduced the mutagenicity of 2-AAF, N-hydroxy-2-AAF and N-acetoxy-2-AAF, and the DNA adducts produced by N-acetoxy-2-AAF to background levels. Acetyl coenzyme A increased the mutations and CHO cytosol-mediated DNA binding of N-hydroxy-2-AAF, but did not substantially increase these responses from N-hydroxy-2-AF. N-Hydroxy-2-AAF was not detectably metabolized by CHO cells. Taken together, these data indicate that CHO cells metabolized N-acetoxy-2-AAF to a reactive derivative by N-deacetylation to N-acetoxy-2-AF, while N-hydroxy-2-AF reacted directly with DNA. The major pathway of N-hydroxy-2-AAF activation appeared to be an initial O-acetylation to N-acetoxy-2-AAF and this occurred to only a limited extent in the CHO cells. N-Hydroxy-2-AAF also seemed to form an additional unknown ester intermediate that gave rise to acetylated DNA adducts. The initial step in the activation of 2-AAF and 2-AF was an N-oxidation to N-hydroxy-2-AAF and N-hydroxy-2-AF, respectively. The limited O-acetylase activity in CHO cells appeared to contribute to the low sensitivity of these cells toward mutation induction by arylamines and arylamides.
将中国仓鼠卵巢(CHO)细胞暴露于2-乙酰氨基芴(2-AAF)、2-氨基芴(2-AF)及其几种N-氧化代谢物中,以研究芳酰胺和芳胺在哺乳动物细胞中产生突变的机制。估计每种化合物在次黄嘌呤-鸟嘌呤磷酸核糖基转移酶位点诱导的突变数(突变体/10⁶ CHO细胞/每毫升化合物纳摩尔数)为:N-乙酰氧基-2-AAF,310;N-羟基-2-AF,3;N-羟基-2-AAF(有和没有肝S9激活),0.7;2-AAF(有S9),0.1;以及2-AF(有S9),0.09。对于每种化合物,还鉴定并定量了DNA加合物,在所有情况下,主要加合物是N-(脱氧鸟苷-8-基)-2-AF。2-AAF和N-羟基-2-AAF也形成少量的N-(脱氧鸟苷-8-基)-2-AAF和3-(脱氧鸟苷-N2-基)-2-AAF。每种衍生物的突变诱导与加合物形成之间的关系与先前报道的N-羟基-2-AF相似。加入脱乙酰酶抑制剂对氧磷,可将2-AAF、N-羟基-2-AAF和N-乙酰氧基-2-AAF的致突变性以及N-乙酰氧基-2-AAF产生的DNA加合物降低至背景水平。乙酰辅酶A增加了N-羟基-2-AAF的突变和CHO细胞溶质介导的DNA结合,但并未显著增加N-羟基-2-AF的这些反应。CHO细胞未检测到N-羟基-2-AAF的代谢。综上所述,这些数据表明,CHO细胞通过N-脱乙酰化将N-乙酰氧基-2-AAF代谢为一种反应性衍生物,生成N-乙酰氧基-2-AF,而N-羟基-2-AF直接与DNA反应。N-羟基-2-AAF的主要激活途径似乎是首先O-乙酰化为N-乙酰氧基-2-AAF,而这在CHO细胞中仅在有限程度上发生。N-羟基-2-AAF似乎还形成了一种额外的未知酯中间体,该中间体产生了乙酰化的DNA加合物。2-AAF和2-AF激活的第一步分别是N-氧化为N-羟基-2-AAF和N-羟基-2-AF。CHO细胞中有限的O-乙酰化酶活性似乎导致了这些细胞对芳胺和芳酰胺诱导突变的低敏感性。